Skip to main content
Fig. 2 | BMC Complementary Medicine and Therapies

Fig. 2

From: Exploring the potential of Gonolobus condurango as a histone deacetylase inhibitor in triple-negative breast cancer cell lines: in vitro study

Fig. 2

High expression of HDAC1 to HDAC4 and low acetylation level in TNBC cell lines. A) HDAC1, HDAC2, HDAC3 and HDAC4 expression on mRNA level in TNBC cell lines HCC38, HCC1395 and HCC1937 compared to the non-tumorigenic breast cell line MCF12A. B) Histone acetylation of HCC38, HCC1937 and HCC1395 compared to the non-tumorigenic breast cell line MCF12A. The results were normalized to cell viability measured by WST-1 assay. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, 1-way ANOVA / Dunnett’s multiple comparison test

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us